Home > Back to Publisher > Report Information

Wound Treatments in Belgium

Euromonitor International
March 1, 2009
44 Pages - SKU: EP2387784

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Belgium

Euromonitor International's Wound Treatments in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market- be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage: sticking plasters, other wound treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?

Get a detailed picture of the wound treatments industry
Identify growth sectors and factors driving change
Understand the competitive environment, the market’s major players and leading brands
Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International

March 2009

Executive Summary

Disappointing Results in 2008 After Strong Growth in 2007

Manufacturers Focus on Leading Brands in Restrictive Environment

Market Still Fragmented, Despite Growing Global Consolidation

Pharmacies Still Monopolise Distribution, Despite Beginning of Deregulation

Rather Bleak Outlook in the Short Term

Key Trends and Developments

Bleak Prospects for Economy, Policy and Thus Purchasing Power

A More Favourable Environment for OTC Healthcare Despite Continuing Conservatism

Mixed Results for Segmentation

Consumer Lifestyles Impact OTC Formats

Related Markets Increasingly Overlap With OTC

Beginning of Deregulation and the Emergence of Internet Sales, But No Real Change in the Dominance of Chemists/pharmacies

Less Room To Manoeuvre for Smaller Players

Market Indicators

Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 2 Life Expectancy at Birth 2003-2008

Market Data

Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 5 OTC Healthcare Company Shares by Value 2004-2008

Table 6 OTC Healthcare Brand Shares by Value 2005-2008

Table 7 Penetration of Private Label by Sector 2003-2008

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

Appendix

OTC Registration and Classification

De-listing Or De-reimbursement

Advertising

Packaging and Labelling

Distribution

Vitamins and Dietary Supplements Registration and Classification

EU Legislation

Self-medication and Preventative Medicine

the Role Played by the Belgian Government

Trend Reversal Over the 2006-2008 Period

Alternative Therapy

Lobbying and Consumer Loyalty Ensure the Ongoing Success of Homeopathy

Other Alternative Therapies Impacted by Fashion

Generics

Switches

Definitions

Sources

Summary 1 Research Sources

Biodiphar NV SA

Strategic Direction

Key Facts

Summary 2 Biodiphar SA: Key Facts

Summary 3 Biodiphar SA: Operational Indicators

Company Background and Production

Competitive Positioning

Summary 4 Biodiphar SA: Competitive Position 2008

Omega Pharma NV

Strategic Direction

Key Facts

Summary 5 Omega Pharma NV: Key Facts

Summary 6 Omega Pharma NV: Operational Indicators

Company Background

Production

Summary 7 Omega Pharma NV: Production Statistics 2005

Competitive Positioning

Summary 8 Omega Pharma NV: Competitive Position 2008

Patch Pharma SA

Strategic Direction

Key Facts

Summary 9 Patch Pharma NV SA: Key Facts

Company Background and Production

Competitive Positioning

Pharmaceutiques Trenker, Laboratoires

Strategic Direction

Key Facts

Summary 10 Pharmaceutiques Trenker, Laboratoires: Key Facts

Summary 11 Pharmaceutiques Trenker, Laboratoires: Operational Indicators

Company Background and Production

Competitive Positioning

Summary 12 Pharmaceutiques Trenker, Laboratoires: Competitive Position 2008

Vemedia Pharma NV

Strategic Direction

Key Facts

Summary 13 Vemedia Pharma NV: Key Facts

Company Background

Production

Summary 14 Vemedia Pharma NV: Production Statistics 2008

Competitive Positioning

Summary 15 Vemedia Pharma NV: Competitive Position 2008

Headlines

Sector Data

Table 12 Sales of Wound Treatments by Subsector: Value 2003-2008

Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008

Table 14 Wound Treatments Company Shares by Value 2004-2008

Table 15 Wound Treatments Brand Shares by Value 2005-2008

Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013

Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013

More Belgium Over-the-Counter Drugs Reports

OTC Pharmaceuticals in Belgium by MarketLine
Introduction OTC Pharmaceuticals in Belgium industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to ...

The Pharmaceutical Market: Belgium (pdf/xls) by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...

Incontinence in Belgium by Euromonitor International
In 2010, incontinence products remained one of the main growth areas in tissue and hygiene in Belgium, achieving current value growth of 8%. Along with ...

NRT Smoking Cessation Aids in Belgium by Euromonitor International
Over the last couple of years anti-tobacco associations and manufacturers of NRT smoking cessation aids complained regarding the lack of significant measures against smoking. While ...

Medicated Skin Care in Belgium by Euromonitor International
Medicated skin care registered a downturn in demand in 2010. Sales seem to have been directly hit by the economic crisis and consumers subsequently watching ...

See all reports like this >>

More Belgium Reports

D&B Country RiskLine Report: Belgium by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Retail Industry Logistics Spending in Belgium to 2014 by Datamonitor
Introduction This databook assesses the prospects for logistics in retail industry. It provides information on total logistics (by value) with respect to nature of sourcing and ...

D&B Country Report: Belgium by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Belgium: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on Belgium, providing an overview of its political, economic and business environments, represented in textual, graph and tabular formats. ...

2007 Belgium Industry & Market Outlook report by Barnes Reports
The 2007 Belgium Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Belgium and 500+ minor industries ...

See all reports like this >>

Wound Treatments in Belgium

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service